Skip to content

Laser Therapy on Controlling Pain During Orthondontic Treatment

Low Level 810nm Laser Therapy on Controlling Pain During a First Stage of Orthondontic Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04628390
Enrollment
60
Registered
2020-11-13
Start date
2020-11-20
Completion date
2021-02-20
Last updated
2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malocclusion

Keywords

Laser, orthodontic, TIP EDGE

Brief summary

To evaluate the effectiveness of pain reduction on a initial orthodontic treatment by using 810nm Diode laser compared to a placebo. Methods: This study will include two parallels groups, 30 adult patients each (mean age 18 - 40) that will be asked to fill a questionnaire related with pain before starting orthodontic treatment with Tip edge technique. Patients from one of the groups will receive laser therapy on both upper and lower maxillary according to the protocol. The patients from the other group will receive a placebo simulating a laser therapy on both maxillary. After the process, both groups will be checked on different times (12hrs-24hrs-48hrs-72hrs after) by filling a questionnaire related with pain each time.

Detailed description

This is a parallel, double-blind, controlled, single-center clinical trial conducted in systemically healthy subjects requiring orthodontic treatment without extractions at the start of treatment in Bogotá, Colombia. Sixty patients (60) will be randomized in a 1: 1 ratio, to either of the two arms of this trial. This study will consist of a single visit by the patient, in this visit the assembly and activation of the upper and lower orthodontic appliances will be carried out. Measurements of the primary outcome variable will be done remotely through a virtual pain monitoring questionnaire through a visual analog scale (Baseline, 12 hours, 24 hours, 48 hours, 72 hours). After Screening a computer-generated scrambling code will be used for allocation in blocks of 6 to the two treatments. The identity of included patients will not be provided to the trial team, in order to preserve the blinded aspect of the trial. The identity of the research treatment associated with each randomization number will be hidden from the trial team and patients. The final analysis is scheduled for when 100% of the patients (60 subjects) reach the 72-hour evaluation.

Interventions

DEVICELaser

The laser application will be carried out only once, immediately after the cementation of the orthodontic appliance.

OTHERPlacebo

Simulation laser application will be carried out only once, immediately after the cementation of the orthodontic appliance.

Sponsors

Fundación Universitaria CIEO
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The patients participating in the clinical trial, the statistician in charge of the data analysis and the orthodontist will be blinded to the interventions carried out. The investigator in charge of applying the intervention will not be blinded.

Intervention model description

Sixty patients (60) will be randomized in a 1: 1 ratio, to either of the two arms of this trial. Measurements of the primary outcome variable will be done remotely through a virtual pain monitoring questionnaire through a visual analog scale (Baseline, 12 hours, 24 hours, 48 hours, 72 hours)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects must have signed and dated an informed consent form approved by the IRB in accordance with regulatory and institutional guidelines. This form must be obtained before performing any procedure related to the protocol that is not part of the subject's normal regimen. * No need extractions * No need Stripping

Exclusion criteria

* Periodontal disease * Pregnant or lactance * Medicated patients (analgesic, anti-inflammatory drugs, systemic corticosteroids, and calcium channel blockers) * Cardiac markpaser

Design outcomes

Primary

MeasureTime frameDescription
Measure the Change in Orthodontic Pain LevelsBaseline (before treatment), 12 hours (after the start of treatment), 24 hours (after the start of treatment) 48 hours (after the start of treatment) 72 hours(after the start of treatment)The evaluation of the difference in pain levels will be determined as a percentage of change and difference in means of pain levels. The difference and the percentage will be calculated by comparing the baseline pain levels observed between the different follow-up times. A rule of three is applied to determine the percentage of change (%) and a subtraction of the pain averages to calculate the difference. Pain analysis will be performed using the visual analog scale (VAS)

Secondary

MeasureTime frameDescription
Need for analgesicBaseline (before treatment), 12 hours (after the start of treatment), 24 hours (after the start of treatment) 48 hours (after the start of treatment) 72 hours(after the start of treatment)Frequency and Need after the treatment

Countries

Colombia

Contacts

Primary ContactJaime E. Donado, DDS
jaimedonadom@yahoo.com3208388047
Backup ContactJulio C. Castro, DDS
jc.castro@unicieo.edu.co3134047035

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026